Literature DB >> 30725301

Timely Use of Biologics in Early Crohn's Disease: The Return of "Hit Hard and Early"?

Catherine Le Berre1,2, Silvio Danese3, Laurent Peyrin-Biroulet4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30725301     DOI： 10.1007/s10620-019-05504-x

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  11 in total

1.  Impact of the early use of immunomodulators or TNF antagonists on bowel damage and surgery in Crohn's disease.

Authors:  E Safroneeva; S R Vavricka; N Fournier; V Pittet; L Peyrin-Biroulet; A Straumann; G Rogler; A M Schoepfer
Journal:  Aliment Pharmacol Ther       Date:  2015-08-14       Impact factor: 8.171

2.  Development of Red Flags Index for Early Referral of Adults with Symptoms and Signs Suggestive of Crohn's Disease: An IOIBD Initiative.

Authors:  Silvio Danese; Gionata Fiorino; Jean-Yves Mary; Peter L Lakatos; Geert D'Haens; Lorenzo Moja; André D'Hoore; Julian Panes; Walter Reinisch; William J Sandborn; Simon P Travis; Séverine Vermeire; Laurent Peyrin-Biroulet; Jean-Fréderic Colombel
Journal:  J Crohns Colitis       Date:  2015-04-23       Impact factor: 9.071

3.  Development of the Paris definition of early Crohn's disease for disease-modification trials: results of an international expert opinion process.

Authors:  Laurent Peyrin-Biroulet; Vincent Billioud; Geert D'Haens; Remo Panaccione; Brian Feagan; Julian Panés; Silvio Danese; Stefan Schreiber; Haruhiko Ogata; Toshifumi Hibi; Peter D R Higgins; Laurent Beaugerie; Yehuda Chowers; Edouard Louis; Flávio Steinwurz; Walter Reinisch; Paul Rutgeerts; Jean-Frédéric Colombel; Simon Travis; William J Sandborn
Journal:  Am J Gastroenterol       Date:  2012-12       Impact factor: 10.864

4.  Risk factors associated with progression to intestinal complications of Crohn's disease in a population-based cohort.

Authors:  Kelvin T Thia; William J Sandborn; William S Harmsen; Alan R Zinsmeister; Edward V Loftus
Journal:  Gastroenterology       Date:  2010-07-14       Impact factor: 22.682

5.  Earlier Anti-Tumor Necrosis Factor Therapy of Crohn's Disease Correlates with Slower Progression of Bowel Damage.

Authors:  Hinaben Panchal; Mathilde Wagner; Manjil Chatterji; Bachir Taouli; Russell McBride; Jeromy R Patterson; Ryan Ungaro; Marla Dubinsky; Judy Cho; David B Sachar
Journal:  Dig Dis Sci       Date:  2019-01-03       Impact factor: 3.199

Review 6.  Preventing Collateral Damage in Crohn's Disease: The Lémann Index.

Authors:  Gionata Fiorino; Cristiana Bonifacio; Laurent Peyrin-Biroulet; Silvio Danese
Journal:  J Crohns Colitis       Date:  2016-01-07       Impact factor: 9.071

Review 7.  Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target.

Authors:  L Peyrin-Biroulet; W Sandborn; B E Sands; W Reinisch; W Bemelman; R V Bryant; G D'Haens; I Dotan; M Dubinsky; B Feagan; G Fiorino; R Gearry; S Krishnareddy; P L Lakatos; E V Loftus; P Marteau; P Munkholm; T B Murdoch; I Ordás; R Panaccione; R H Riddell; J Ruel; D T Rubin; M Samaan; C A Siegel; M S Silverberg; J Stoker; S Schreiber; S Travis; G Van Assche; S Danese; J Panes; G Bouguen; S O'Donnell; B Pariente; S Winer; S Hanauer; J-F Colombel
Journal:  Am J Gastroenterol       Date:  2015-08-25       Impact factor: 10.864

8.  Development of the Lémann index to assess digestive tract damage in patients with Crohn's disease.

Authors:  Benjamin Pariente; Jean-Yves Mary; Silvio Danese; Yehuda Chowers; Peter De Cruz; Geert D'Haens; Edward V Loftus; Edouard Louis; Julian Panés; Jürgen Schölmerich; Stefan Schreiber; Maurizio Vecchi; Julien Branche; David Bruining; Gionata Fiorino; Matthias Herzog; Michael A Kamm; Amir Klein; Maïté Lewin; Paul Meunier; Ingrid Ordas; Ulrike Strauch; Gian-Eugenio Tontini; Anne-Marie Zagdanski; Cristiana Bonifacio; Jordi Rimola; Maria Nachury; Christophe Leroy; William Sandborn; Jean-Frédéric Colombel; Jacques Cosnes
Journal:  Gastroenterology       Date:  2014-09-21       Impact factor: 22.682

9.  Prevalence of Bowel Damage Assessed by Cross-Sectional Imaging in Early Crohn's Disease and its Impact on Disease Outcome.

Authors:  Gionata Fiorino; Mathilde Morin; Stefanos Bonovas; Cristiana Bonifacio; Antonino Spinelli; Adeline Germain; Valérie Laurent; Camille Zallot; Laurent Peyrin-Biroulet; Silvio Danese
Journal:  J Crohns Colitis       Date:  2017-03-01       Impact factor: 9.071

10.  Development of the Crohn's disease digestive damage score, the Lémann score.

Authors:  Benjamin Pariente; Jacques Cosnes; Silvio Danese; William J Sandborn; Maïté Lewin; Joel G Fletcher; Yehuda Chowers; Geert D'Haens; Brian G Feagan; Toshifumi Hibi; Daniel W Hommes; E Jan Irvine; Michael A Kamm; Edward V Loftus; Edouard Louis; Pierre Michetti; Pia Munkholm; Tom Oresland; Julian Panés; Laurent Peyrin-Biroulet; Walter Reinisch; Bruce E Sands; Juergen Schoelmerich; Stefan Schreiber; Herbert Tilg; Simon Travis; Gert van Assche; Maurizio Vecchi; Jean-Yves Mary; Jean-Frédéric Colombel; Marc Lémann
Journal:  Inflamm Bowel Dis       Date:  2010-11-28       Impact factor: 5.325
View more
  1 in total

Review 1.  Biosimilar-to-Biosimilar Switching: What is the Rationale and Current Experience?

Authors:  Eduardo Mysler; Valderilio Feijó Azevedo; Silvio Danese; Daniel Alvarez; Noriko Iikuni; Beverly Ingram; Markus Mueller; Laurent Peyrin-Biroulet
Journal:  Drugs       Date:  2021-10-27       Impact factor: 9.546
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.